Advances in our understanding of the control of early human embryonic development could offer solutions to the moral dilemmas associated with human embryonic stem cell research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Austriaco, N.P. Natl. Cathol. Bioeth. Q. 2, 659–683 (2002).
Guenin, L.M. Mayo Clin. Proc. 79, 801–808 (2004).
Hurlbut, W.B. Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. A working paper discussed at the December 2004 meeting of the President's Council on Bioethics (The President's Council on Bioethics, Washington, DC, December, 2004). <http://bioethics.gov/background/hurlbut.html> Accessed May 20, 2005.
Sandel, M.J. N. Engl. J. Med. 351, 207–209 (2004).
'Is it possible to say when human life begins? Can ethical, legal, and biological conceptions of the human embryo converge?' Invitation-only conference convened by the San Diego Center for Ethics in Science and Technology in conjunction with the Burnham Institute for Medical Research, La Jolla, California, July USA, 14, 2004.
'Human embryonic stem cell research: are there scientific solutions to the moral dilemmas?' Invitation-only conference convened by the San Diego Center for Ethics in Science and Technology (in conjunction with the Burnham Institute for Medical Research), University of San Diego, San Diego, California, USA, June 6–7, 2005.
Zucker, H.A., Landry, D.W. & Hurlbut, W. Session 6: seeking morally unproblematic sources of human embryonic stem cells (The President's Council on Bioethics, Washington, DC, December 3, 2004). <http://www.bioethics.gov/transcripts/dec04/session6.html> Accessed May 20, 2005.
The President's Council on Bioethics. Alternative sources of human pluripotent stem cells: a white paper (President's Council on Bioethics, Washington, DC, USA, May 2005). <http://www.bioethics.gov/reports/white_paper/index.html>
Bertocchini, F., Skromne, I., Wolpert, L. & Stern, C.D. Development 131, 3381–3390 (2004).
Camus, A., Perea-Gomez, A. & Collignon, J. in Handbook of Stem Cells, vol. 1 (Lanza, R., ed.) 129–142 (Academic Press, New York, 2004).
Dobson, A.T. et al. Hum. Mol. Genet. 13, 1461–1470 (2004).
Gong, Y., Mo, C. & Fraser, S.E. Nature 430, 689–693 (2004).
Rossant, J. Semin. Cell Dev. Biol. 15, 573–581 (2004).
Rossant, J. & Tam, P.P. Dev. Cell 7, 155–164 (2004).
Zernicka-Goetz, M. Semin. Cell Dev. Biol. 15, 563–572 (2004).
Zhang, L. et al. Science 306, 114–117 (2004).
Melton, D.A., Daley, G.Q. & Jennings, C.G. N. Engl. J. Med. 351, 2791–2792 (2004).
Meissner, A. & Jaenisch, R. Nature 439, 212–215 (2006).
Deb, K., Sivaguru, M., Yong, H.Y. & Roberts, R.M. Science 311, 992–996 (2006).
Santos, F., Hendrich, B., Reik, W. & Dean, W. Dev. Biol. 241, 172–182 (2002).
Deobagkar, D.D., Liebler, M., Graessmann, M. & Graessmann, A. Proc. Natl. Acad. Sci. USA 87, 1691–1695 (1990).
Jain, M. Science 297, 102–104 (2002).
Park, K.I. et al. Gene Ther. 9, 613–624 (2002).
Cowan, C.A., Atienza, J., Melton, D.A. & Eggan, K. Science 309, 1369–1373 (2005).
Chung, Y. et al. Nature 439, 216–219 (2006)
Landry, D.W. & Zucker, H.A. J. Clin. Invest. 114, 1184–1186 (2004).
Lanza, R. et al. Science 295, 819 (2002).
Berg, P., Daley, G.Q. & Goldstein, L.S.B. Stem cell 'alternatives' fog the debate. Washington Post July 19, 2005, p. A21.
Russell, W.M.S. & Burch, R.L. Principles of Humane Animal Experimentation (Charles C. Thomas, Springfield, Illinois, USA, 1959).
Imitola, J. et al. Am. J. Pathol. 164, 1615–1625 (2004).
Hori, J. et al. Stem Cells 21, 405–416 (2003).
Flax, J.D. et al. Nat. Biotechnol. 16, 1033–1039 (1998).
Acknowledgements
We thank the participants of two conferences, both of which were sponsored by the Center for Ethics in Science & Technology (in conjunction with The Burnham Institute for Medical Research). At the first, entitled 'Is it possible to say when human life begins?', participants represented a variety of national constituencies, including theologians, philosophers, scientists, healthcare professionals, business leaders, lawyers, legislators, policy makers and others. Speakers and panelists included Nicanor Austriaco, Louis Guenin, William Hurlbut, Jeffrey Kahn, Frances Kamm, Paul Lauritzen, William Saunders, Michael Shapiro and Laurie Zoloth. The second, a roundtable workshop entitled 'Human embryonic stem cell research: are there scientific solutions to the moral dilemmas?', included the following participants: Mina Alikani, Maureen Condic, Mary Devereaux, Kevin Eggan, Lawrence Goldstein, William Hurlbut, Frances Kamm, Tadeusz Pacholczyk, Adam Schulman, Alan Trounson, Derek van der Kooy and Howard Zucker. This paper is not intended as a definitive representation of the views of any of the presenters or participants in the two conferences. We also thank Linda Roux for helpful editorial comments. We thank The Burnham Institute, The Legler Benbough Foundation, the Parker Foundation, the Anita B. and Howard S. Richmond Foundation, and Children's Neurobiological Solutions for financial support. E.Y.S. thanks Mark Parker in his group for performing the NANOG RT-PCR.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snyder, E., Hinman, L. & Kalichman, M. Can science resolve the ethical impasse in stem cell research?. Nat Biotechnol 24, 397–400 (2006). https://doi.org/10.1038/nbt0406-397
Issue Date:
DOI: https://doi.org/10.1038/nbt0406-397
This article is cited by
-
Embryonic Stem Cell Patents and Human Dignity
Health Care Analysis (2007)
-
Erratum: Corrigendum: Can science resolve the ethical impasse in stem cell research?
Nature Biotechnology (2006)